Cytokinetics Inc

Common Name

Cytokinetics

Country

United States

Sector

Healthcare

Industry

Biotechnology

Employees

498

Ticker

CYTK

Exchange

NASDAQ/NGS

Website

cytokinetics.com

Description

Cytokinetics, Incorporated is a biopharmaceutical company specializing in the discovery, development, and commercialization of innovative muscle activators and inhibitors. Its primary mission is to ad... Show more

Financial Statements of Cytokinetics

Below are the financial statements of Cytokinetics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	94.86^a	113.02^a
Short-term investments	981.16^a	501.8^a
Accounts receivable	16.65^a	1.28^a
Prepaid expenses and other current assets	15.28^a	11.94^a
Total current assets	1,107.94^a	628.05^a
Assets	—	—
Long-term investments	145.06^a	40.53^a
Property and equipment, net	65.82^a	68.75^a
Operating lease right-of-use assets	75.16^a	78.99^a
Other assets	7.71^a	8^a
Total assets	1,401.67^a	824.32^a
Current liabilities	—	—
Accounts payable	20.37^a	21.51^a
Accrued liabilities	55.32^a	42.64^a
Short-term operating lease liabilities	18.98^a	17.89^a
Current portion of long-term debt	11.52^a	10.08^a
Derivative liabilities measured at fair value	11.3^a	0^a
Deferred revenue	52.37^a	0^a
Other current liabilities	9.81^a	10.56^a
Total current liabilities	179.67^a	102.68^a
Liabilities and stockholders' deficit	—	—
Term loans, net	93.23^a	58.38^a
Convertible notes, net	552.37^a	548.99^a
Liabilities related to revenue participation right purchase agreements, net	462.19^a	379.98^a
Long-term operating lease liabilities	112.58^a	120.43^a
Liabilities related to RPI Transactions measured at fair value	137^a	0^a
Other non-current liabilities	0^a	0.19^a
Total liabilities	1,537.05^a	1,210.64^a
Stockholders' deficit	—	—
Preferred stock	0^a	0^a
Common stock	0.12^a	0.1^a
Additional paid-in capital	2,563.88^a	1,725.82^a
Accumulated other comprehensive income (loss)	2.4^a	-0.01^a
Accumulated deficit	-2,701.76^a	-2,112.24^a
Total stockholders' deficit	-135.37^a	-386.32^a
Total liabilities and stockholders' deficit	1,401.67^a	824.32^a

Verified Sources Behind Cytokinetics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Cytokinetics’s data sources below and access millions more through our Disclosure Search.

a. Cytokinetics's Annual Report 2024

Trace every data point back to Cytokinetics’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Cytokinetics Inc

Financial Statements of Cytokinetics

Verified Sources Behind Cytokinetics’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Arcellx Inc

Vericel Corp

Kymera Therapeutics Inc

Immunovant Inc

Ultragenyx Pharmaceutical Inc

Crinetics Pharmaceuticals Inc